• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉注射免疫球蛋白G介导的T细胞增殖抑制反映了一种内源性机制,通过该机制IgG调节T细胞活化。

Intravenous immunoglobulin G-mediated inhibition of T-cell proliferation reflects an endogenous mechanism by which IgG modulates T-cell activation.

作者信息

MacMillan Heather F, Lee Tim, Issekutz Andrew C

机构信息

Department of Pathology, Dalhousie University, Nova Scotia, Canada.

出版信息

Clin Immunol. 2009 Aug;132(2):222-33. doi: 10.1016/j.clim.2009.04.002. Epub 2009 May 17.

DOI:10.1016/j.clim.2009.04.002
PMID:19447680
Abstract

Commercial intravenous immunoglobulin G (IVIG) at high doses has therapeutic benefit in autoimmune and inflammatory diseases. It has been shown to inhibit T-cell function but the mechanisms are unclear. Inhibition could result from IVIG processing, donor pooling or intrinsic downregulatory activity of IgG. To address these points, we compared the effects on T-cell activation of IVIG, Fab(2) fragment and IgG isolated from single-donor plasma. We also investigated the role of accessory cells in the IVIG effects using highly purified T cells stimulated through CD3 and CD28 engagement. T-cell proliferation was evaluated by Oregon Green 488 dye dilution and (3)H-thymidine incorporation. IVIG, Fab(2) fragment of IVIG and autologous, single-donor IgG significantly inhibited T-cell proliferation (35-50%), even in the absence of accessory cells. Depletion of IgG from plasma used for culture significantly increased (by 50%) the T-cell proliferation. The addition of physiological concentrations of single-donor, autologous IgG or IVIG to IgG-depleted plasma reduced T-cell proliferation to levels observed in normal plasma. Therefore, donor pooling in IVIG and accessory cells are not required for inhibition of T-cell proliferation by IVIG and the Fab(2) region is sufficient to mediate this inhibition. Suppression of T-cell activation by IVIG likely reflects a physiologic, endogenous mechanism of IgG-mediated regulation of T-cell activation.

摘要

高剂量的商业静脉注射免疫球蛋白G(IVIG)在自身免疫性疾病和炎症性疾病中具有治疗作用。已证明其可抑制T细胞功能,但机制尚不清楚。抑制作用可能源于IVIG的加工、供体混合或IgG固有的下调活性。为解决这些问题,我们比较了IVIG、Fab(2)片段和从单供体血浆中分离的IgG对T细胞活化的影响。我们还使用通过CD3和CD28结合刺激的高度纯化T细胞研究了辅助细胞在IVIG作用中的作用。通过俄勒冈绿488染料稀释和³H-胸腺嘧啶掺入评估T细胞增殖。IVIG、IVIG的Fab(2)片段以及自体单供体IgG均显著抑制T细胞增殖(35%-50%),即使在没有辅助细胞的情况下也是如此。用于培养的血浆中IgG的消耗显著增加(50%)T细胞增殖。向IgG耗尽的血浆中添加生理浓度的单供体、自体IgG或IVIG可将T细胞增殖降低至正常血浆中观察到的水平。因此,IVIG中的供体混合和辅助细胞并非IVIG抑制T细胞增殖所必需,且Fab(2)区域足以介导这种抑制作用。IVIG对T细胞活化的抑制可能反映了IgG介导的T细胞活化调节的一种生理、内源性机制。

相似文献

1
Intravenous immunoglobulin G-mediated inhibition of T-cell proliferation reflects an endogenous mechanism by which IgG modulates T-cell activation.静脉注射免疫球蛋白G介导的T细胞增殖抑制反映了一种内源性机制,通过该机制IgG调节T细胞活化。
Clin Immunol. 2009 Aug;132(2):222-33. doi: 10.1016/j.clim.2009.04.002. Epub 2009 May 17.
2
Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.非抗原特异性CD8 + T抑制淋巴细胞起源于CD8 + CD28 - T细胞,并抑制T细胞增殖和CTL功能。
Hum Immunol. 2004 Feb;65(2):142-56. doi: 10.1016/j.humimm.2003.12.001.
3
Effects of human intravenous immunoglobulin on canine monocytes and lymphocytes.人静脉注射免疫球蛋白对犬单核细胞和淋巴细胞的影响。
Am J Vet Res. 1998 Dec;59(12):1568-74.
4
Intravenous IgG (IVIG) and subcutaneous IgG (SCIG) preparations have comparable inhibitory effect on T cell activation, which is not dependent on IgG sialylation, monocytes or B cells.静脉注射免疫球蛋白(IVIG)和皮下注射免疫球蛋白(SCIG)制剂对T细胞活化具有相当的抑制作用,这并不依赖于IgG的唾液酸化、单核细胞或B细胞。
Clin Immunol. 2015 Oct;160(2):123-32. doi: 10.1016/j.clim.2015.05.003. Epub 2015 May 14.
5
Exogenous immunoglobulin downregulates T-cell receptor signaling and cytokine production.外源性免疫球蛋白可下调 T 细胞受体信号和细胞因子产生。
Pediatr Allergy Immunol. 2012 Feb;23(1):88-95. doi: 10.1111/j.1399-3038.2010.01129.x. Epub 2011 Jan 25.
6
Superior immunomodulatory effects of intravenous immunoglobulins on human T-cells and dendritic cells: comparison to calcineurin inhibitors.静脉注射免疫球蛋白对人T细胞和树突状细胞的卓越免疫调节作用:与钙调神经磷酸酶抑制剂的比较。
Transplantation. 2006 Jun 27;81(12):1725-34. doi: 10.1097/01.tp.0000226073.20185.b1.
7
IVIg prevents the in vitro activation of T cells by neutralizing the T cell activators.IVIg 通过中和 T 细胞激活剂来防止 T 细胞的体外激活。
Immunol Lett. 2013 Feb;150(1-2):54-60. doi: 10.1016/j.imlet.2012.12.011. Epub 2013 Jan 4.
8
Differential modulation of cord blood and peripheral blood monocytes by intravenous immunoglobulin.静脉注射免疫球蛋白对脐血和外周血单核细胞的差异调节。
Cytometry B Clin Cytom. 2012 Jan;82(1):26-34. doi: 10.1002/cyto.b.20609. Epub 2011 Aug 2.
9
sHLA-I contaminating molecules as novel mechanism of ex vivo/in vitro transcriptional and posttranscriptional modulation of transforming growth factor-beta in CD8+ T lymphocytes and neutrophils after intravenous immunoglobulin treatment.静脉注射免疫球蛋白治疗后,sHLA-I 污染分子作为 CD8+ T 淋巴细胞和嗜中性粒细胞中转化生长因子-β的体外/转录和转录后调节的新机制。
Transfusion. 2010 Mar;50(3):547-55. doi: 10.1111/j.1537-2995.2009.02479.x. Epub 2009 Nov 9.
10
Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody.非促有丝分裂抗CD3抗体对抗原特异性T细胞反应的调节
Int Immunopharmacol. 2006 Jun;6(6):880-91. doi: 10.1016/j.intimp.2005.12.009. Epub 2006 Jan 27.

引用本文的文献

1
Abrogation of neutrophil inflammatory pathways and potential reduction of neutrophil-related factors in COVID-19 by intravenous immunoglobulin.静脉注射免疫球蛋白对 COVID-19 中性粒细胞炎症途径的阻断作用及其对中性粒细胞相关因子的潜在减少作用。
Front Immunol. 2022 Oct 20;13:993720. doi: 10.3389/fimmu.2022.993720. eCollection 2022.
2
Role of HLA-I Structural Variants and the Polyreactive Antibodies They Generate in Immune Homeostasis.HLA-I结构变体及其产生的多反应性抗体在免疫稳态中的作用。
Antibodies (Basel). 2022 Sep 8;11(3):58. doi: 10.3390/antib11030058.
3
IgG stimulated β2 adrenergic receptor activation is attenuated in patients with ME/CFS.
在肌痛性脑脊髓炎/慢性疲劳综合征(ME/CFS)患者中,免疫球蛋白G(IgG)刺激的β2肾上腺素能受体激活减弱。
Brain Behav Immun Health. 2020 Feb 5;3:100047. doi: 10.1016/j.bbih.2020.100047. eCollection 2020 Mar.
4
Therapeutic Potential of HLA-I Polyreactive mAbs Mimicking the HLA-I Polyreactivity and Immunoregulatory Functions of IVIg.模仿静脉注射免疫球蛋白(IVIg)的HLA-I多反应性及免疫调节功能的HLA-I多反应性单克隆抗体的治疗潜力
Vaccines (Basel). 2021 Jun 21;9(6):680. doi: 10.3390/vaccines9060680.
5
Immunomodulatory effects of different intravenous immunoglobulin preparations in chronic lymphocytic leukemia.不同静脉注射免疫球蛋白制剂在慢性淋巴细胞白血病中的免疫调节作用。
Sci Rep. 2021 Jun 21;11(1):12926. doi: 10.1038/s41598-021-92412-8.
6
Differential immunomodulation of T-cells by immunoglobulin replacement therapy in primary and secondary antibody deficiency.原发性和继发性抗体缺陷症中免疫球蛋白替代疗法对 T 细胞的差异化免疫调节。
PLoS One. 2019 Oct 15;14(10):e0223861. doi: 10.1371/journal.pone.0223861. eCollection 2019.
7
Therapeutic Potential of Intravenous Immunoglobulin in Acute Brain Injury.静脉注射免疫球蛋白在急性脑损伤中的治疗潜力
Front Immunol. 2017 Jul 31;8:875. doi: 10.3389/fimmu.2017.00875. eCollection 2017.
8
Modulatory Effects of Antibody Replacement Therapy to Innate and Adaptive Immune Cells.抗体替代疗法对固有免疫细胞和适应性免疫细胞的调节作用。
Front Immunol. 2017 Jun 16;8:697. doi: 10.3389/fimmu.2017.00697. eCollection 2017.
9
HLA Class Ia and Ib Polyreactive Anti-HLA-E IgG2a Monoclonal Antibodies (TFL-006 and TFL-007) Suppress Anti-HLA IgG Production by CD19+ B Cells and Proliferation of CD4+ T Cells While Upregulating Tregs.HLA Ⅰ类和 Ⅰ类多反应性抗-HLA-E IgG2a 单克隆抗体(TFL-006 和 TFL-007)抑制 CD19+B 细胞产生抗-HLA IgG 和 CD4+T 细胞增殖,同时上调 Tregs。
J Immunol Res. 2017;2017:3475926. doi: 10.1155/2017/3475926. Epub 2017 May 28.
10
Immunological evidence and regulatory potential for cell-penetrating antibodies in intravenous immunoglobulin.静脉注射用免疫球蛋白中穿透细胞抗体的免疫证据和调节潜力。
Clin Transl Immunology. 2015 Oct 2;4(10):e42. doi: 10.1038/cti.2015.18. eCollection 2015 Oct.